Scleroderma, Diffuse: all 534 studies
Page 3 of 6. Open to participants first (115), then studies with results posted, then the rest; newest registration first within each.
- Scleroderma: Cyclophosphamide or TransplantationCompletedNCT00114530Phase 2/3Results posted
- Scleroderma Lung DiseaseCompletedNCT00004563Phase 3Results posted
- Personalized Online Occupational Therapy Intervention for Adults With SclerodermaCompletedNCT07661836Not applicable
- RENEW-AI: Personalizing Scleroderma Management With an AI Health CoachCompletedNCT06999226Not applicable
- Self-management Telehealth Program for SclerodermaCompletedNCT06990386Not applicable
- Clinical Usefulness and Influence on Esophageal Motility of Pyridostigmine for Dysphagia in Systemic SclerosisWithdrawnNCT06915181Phase 2
- Brain Boost Program to Improve Cognitive Function in People With Systemic SclerosisActive, not recruitingNCT06880627Not applicable
- Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)Active, not recruitingNCT06843239Phase 2
- Evaluating the Effect of Questionnaire Context on the Reporting of Somatic Items Among People With Systemic SclerosisCompletedNCT06772896Not applicable
- Development and Evaluation of an Evidence-based Education Program for People With Hand Dysfunction in SclerodermaActive, not recruitingNCT06697561Not applicable
- Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic SclerosisActive, not recruitingNCT06655896Phase 2
- A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune DiseaseCompletedNCT06587828
- Validity and Reliability of the Turkish Version of HAnDECompletedNCT06536595
- A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic SclerosisActive, not recruitingNCT06470048Phase 2
- Exercise With Scleroderma Functional OutcomesCompletedNCT06425653Not applicable
- KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic SclerosisTerminatedNCT06400303Phase 1/2
- A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc)WithdrawnNCT06377228Phase 1
- Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1CompletedNCT06373263Not applicable
- Making it Work Program for Systemic SclerosisCompletedNCT06338722Not applicable
- Early Diagnosis of SSc in the General Rheumatology Clinic - PilotCompletedNCT06291142
- A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune DiseasesActive, not recruitingNCT06255028Phase 1
- Effects of Fractional CO2 Laser Treatment on Vaginal Symptoms and Sexual Dysfunction in Women With Systemic SclerosisCompletedNCT06231433Phase 2/3
- CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101Active, not recruitingNCT06152172Phase 1
- The Effect of a Self-Management Program on Individuals With SclerodermaCompletedNCT06095921Not applicable
- Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male SubjectsCompletedNCT06037577Phase 1
- Clinical Risk Assessment of Cognitive Function in Systemic Autoimmune DiseasesActive, not recruitingNCT06029335
- A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary FibrosisActive, not recruitingNCT06025578Phase 3
- Hyaluronidase Via LADD Scleroderma-induced MicrostomiaCompletedNCT05995626Early Phase 1
- Rituxmab Versus IL-6 in Treating ILDCompletedNCT05963048Phase 2/3
- Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)Active, not recruitingNCT05925803Phase 3
- Ultrasound Therapy and Manual Therapy in Digital Ischemic UlcersCompletedNCT05907200Not applicable
- Co-designing Digital Ulcers Opportunities With Patients and CliniciansStatus unknownNCT05785403
- Klotho and Mineral Bone Density in Systemic SclerosisCompletedNCT05777954
- Sleep Quality, Stress, Depression, Blood Pressure Responses to Diaphragmatic Respiratory Exercise in Systemic SclerosisStatus unknownNCT05623917Not applicable
- Phenotyping of Chronic Pain in Diffused Systemic SclerodermaCompletedNCT05622578Not applicable
- Stress, Scleroderma and Quality of LifeCompletedNCT05617066Not applicable
- Quantification and Characterization of Circulating Epithelial and Endothelial Cells in Gougerot-Sjögren Syndrome, Compared to Systemic SclerosisCompletedNCT05528809Not applicable
- Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis?Status unknownNCT05482594
- The Effect of Cognitive Exercise Therapy Approach in Individuals With Systemic SclerosisCompletedNCT05453071Not applicable
- Effectiveness of Cannabinoids on Appetite in SclerodermaCompletedNCT05416697Phase 3
- Novel Splinting Technique Using 3D ModelsStatus unknownNCT05351060Not applicable
- RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic SclerosisTerminatedNCT05298358Phase 1
- Structural and Functional Impairment of Multiple Organs in Patients With Systemic Sclerosis: A MR Imaging StudyStatus unknownNCT05297474
- Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)Active, not recruitingNCT05270668Phase 2
- Exercise in People With Systemic SclerosisCompletedNCT05234671Not applicable
- Treatment of Systemic Sclerosis With Autologous Regulatory Т-cellsStatus unknownNCT05214014Phase 1/2
- Rheopheresis for Raynaud's and Digital Ulcers in Systemic SclerosisStatus unknownNCT05204784Not applicable
- MRI for Screening and Monitoring Scleroderma ILDCompletedNCT05204355
- Effectiveness of the EmoLED Medical Device in the Healing of Digital Ulcers in Patients With Scleroderma.TerminatedNCT05181644Not applicable
- Efficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung DiseaseWithdrawnNCT05177471
- Scleroderma: Functional Disability Between the Dominant and Contralateral Hand.CompletedNCT05171114Not applicable
- Open Label Extension Study of Brentuximab Vedotin in Early dcSScCompletedNCT05149768Phase 2
- Evaluation of Slit2 in Systemic Lupus Erythematosus and Systemic Sclerosis PatientsStatus unknownNCT05105217
- A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic SclerosisWithdrawnNCT05098145Phase 1/2
- A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory SclerodermaStatus unknownNCT05085444Early Phase 1
- Upper Extremity Home Exercises in Patients With SclerodermaCompletedNCT05080738Not applicable
- The Effects of Telerehabilitation Based Exercise Program in Patients With Systemic SclerosisStatus unknownNCT05078749Not applicable
- Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic SclerosisTerminatedNCT05016804Phase 1
- Impact of Transcutaneous Auricular Vagus Nerve Stimulation on Digestive Symptoms in Systemic Sclerosis Systemic SclerosisCompletedNCT04971018Not applicable
- A Study of MK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002)TerminatedNCT04948554Phase 1
- Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot)Active, not recruitingNCT04927390Phase 2
- RENEW Scleroderma: A Peer-Mentored, Web Intervention for Resilience-based, Energy Management to Enhance Wellbeing and FatigueCompletedNCT04908943Not applicable
- Effect of Ozone Therapy for the Treatment of Digital Ulcer in Patients With SScCompletedNCT04826419Not applicable
- Immunomodulating Effects of Supplementation With 25-OH Vitamin DCompletedNCT04822038Not applicable
- Study of the Intestinal Microbiota of Patients With Systemic SclerosisStatus unknownNCT04791280
- The Influence of Extracorporeal Photopheresis on Skin SclerosisCompletedNCT04752397
- Autologous Fat Grafting in the Treatment of Critical Limb IschaemiaStatus unknownNCT04746599Not applicable
- Prevalence of Hyperprolactinemia in Systemic SclerodermaCompletedNCT04746313
- Telerehabilitation on Hand-Affected SclerodermaCompletedNCT04684225Not applicable
- Effects of a Supervised Exercise Program and a Home Exercise Program in Patients With Systemic SclerosisCompletedNCT04675502Not applicable
- Functional Exercise Tests in Patients With Systemic SclerosisStatus unknownNCT04650659
- Evaluating Gut Imaging and Stool Biomarkers in Patients With Scleroderma-associated Gastrointestinal DiseaseStatus unknownNCT04630782
- Effect of the Use of Specific Oral Hygiene Devices on Gingival Health Among Patients With Systemic SclerosisTerminatedNCT04627857Not applicable
- Cardiac Assessment by PV Loop in IPAH and Scleroderma PAHCompletedNCT04610788
- Feasibility and Preliminary Effects of the Resilience-based, Energy Management to Enhance Wellbeing in Systemic Sclerosis (RENEW) InterventionCompletedNCT04588714Not applicable
- Effectiveness of Telerehabilitation on SclerodermaStatus unknownNCT04563481Not applicable
- Optical Coherence Tomography Imaging in Systemic SclerosisCompletedNCT04532151Not applicable
- The Effects of Botulinum Toxin on Oral Aperture in Patients With SclerodermaCompletedNCT04523506Early Phase 1
- Iguratimod in Systemic SclerosisStatus unknownNCT04515706Not applicable
- Yoga Adjunct for SclerodermaCompletedNCT04491396Not applicable
- Utility of Breath-holding Test in Systemic SclerosisCompletedNCT04484948Not applicable
- Effectiveness of a Home-based, Self-administered Exercise Program for Hands in Patients With Systemic SclerosisCompletedNCT04481984Not applicable
- Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic SclerosisCompletedNCT04464434Phase 4
- Effects of Fibromyalgia Syndrome in Patients With Systemic SclerosisCompletedNCT04411498
- Online Fatigue Intervention Program for People With SclerodermaCompletedNCT04401943Not applicable
- Safety Of Fat Micrografts With Adipose-Derived Stromal Vascular Fraction In Hands Of Patients With Systemic SclerosisCompletedNCT04387825Phase 2
- Is a History of Pre-eclampsia a Risk Factor for Vascular Phenotype in Women With Systemic Sclerosis?CompletedNCT04363021
- Screening Patients With Diabetes Mellitus for the Presence of Skin Disorder of ScleredemaStatus unknownNCT04335396
- Sirtuin 3 and Sirtuin 7 in Systemic SclerosisStatus unknownNCT04303208Not applicable
- Safety and Efficacy of Anaerobic Cultivated Human Intestinal Microbiome Transplantation in Systemic Sclerosis (ReSScue)CompletedNCT04300426Phase 2
- A Study of the Efficacy and Safety of Rituximab in Participants With Systemic SclerosisCompletedNCT04274257Phase 2/3
- Mouth Handicap in Systemic SclerosisCompletedNCT04273386Not applicable
- SPIN Self-Management Feasibility Trial With Progression to Full-scale Trial (SPIN-SELF)CompletedNCT04246528Not applicable
- IgG-4 Levels in Systemic SclerosisCompletedNCT04219592
- Effectiveness of Tai Chi Exercise Program in Scleroderma PatientsCompletedNCT04214925Not applicable
- Trial on Outpatients With Systemic Sclerosis Treated With Well-Being Therapy or With a Control TherapyCompletedNCT04212247Not applicable
- Systemic Sclerosis and Jak Inhibitors : Emphasis on MacrophagesActive, not recruitingNCT04206644
- Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized SclerodermaCompletedNCT04200755Phase 2
- The Effect of Physiotherapy Program in Scleroderma PatientsCompletedNCT04179292Not applicable
- Assessment of the Prevalence of Olfactory Disorders in Systemic SclerodermaTerminatedNCT04178616Not applicable